🕵️ Avanos Medical, Inc. ($AVNS)
SEC insider & ownership activity, last 12 months · CIK 1606498 · every row links its SEC filing
Over the last 12 months insiders sold $165K with no open-market buying against it. Holbrook Kerr sold $165K (Nov). One red-flag 8-K in the window: Delisting notice (3.01), Jul 27, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
0 buyers, $0 (0 lots) · 1 seller, $165K (4 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Holbrook Kerr | 0 | – | 4 | $165K | Nov 18, 2025 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| BlackRock, Inc. | 14.8% | 13G | Apr 30, 2025 | filing ↗ | |
| Vanguard Capital Management | 5.0% | 13G | Jul 31, 2026 | filing ↗ |
Planned insider sales (Form 144)
| Seller | Planned | Approx. sale date | |
|---|---|---|---|
| Holbrook Kerr | $165K | Nov 18, 2025 | filing ↗ |
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Jul 27, 2026 | filing ↗ |
| Agreement terminated (1.02) | Jul 27, 2026 | filing ↗ |
| Acquisition or disposition (2.01) | Jul 27, 2026 | filing ↗ |
| New financial obligation (2.03) | Jul 27, 2026 | filing ↗ |
| Delisting notice (3.01) | Jul 27, 2026 | filing ↗ |
| Material Modifications to Rights of Security Holders (3.03) | Jul 27, 2026 | filing ↗ |
| Change of control (5.01) | Jul 27, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 27, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Jul 27, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 27, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jul 22, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 22, 2026 | filing ↗ |
| Other events (8.01) | Jul 14, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 2, 2026 | filing ↗ |
| Earnings (2.02) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 13, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Apr 13, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 13, 2026 | filing ↗ |
| Officer/director changes (5.02) | Mar 6, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 6, 2026 | filing ↗ |
| Material agreement (1.01) | Feb 25, 2026 | filing ↗ |
| Other events (8.01) | Feb 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 25, 2026 | filing ↗ |
| Earnings (2.02) | Feb 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Feb 24, 2026 | filing ↗ |